mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
0.44 |
2e-17 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
3e-10 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
6e-09 |
mRNA |
Methotrexate |
GDSC1000 |
pan-cancer |
AAC |
0.31 |
7e-09 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
9e-09 |
mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
1e-08 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
6e-08 |
mRNA |
AZD1480 |
CTRPv2 |
pan-cancer |
AAC |
0.36 |
1e-07 |
mRNA |
BRD-K14844214 |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
2e-06 |
mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
0.27 |
2e-06 |